View of Drug Utilization Pattern of World’s First T-DM1 Biosimilar (UJVIRATM) For Her2+ Breast Cancer in First Year of Its Availability – An Indian Context

Return to Article Details Drug Utilization Pattern of World’s First T-DM1 Biosimilar (UJVIRATM) For Her2+ Breast Cancer in First Year of Its Availability – An Indian Context Download Download PDF